Clinical Trial Update: Off-therapy Response After Stopping Entecavir or Tenofovir

View source ↗

Summary

A clinical trial assessing the off-therapy response after stopping entecavir or tenofovir in chronic hepatitis B patients; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Viread (tenofovir disoproxil fumarate)

Snippet

Sponsor: Kaohsiung Medical University Chung-Ho Memorial Hospital | Conditions: Chronic Hepatitis b | Status: UNKNOWN